Skip to main content

Table 2 Treatment characteristics

From: Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment

Characteristics

N (%)

Receiving treatment

 Yes

78 (91.7)

 No

7 (8.3)

Radiotherapy of primary tumor

 Yes

32 (37.6)

 No

53 (62.4)

Cycles of chemotherapy

 0

7 (8.2)

 1-5

36 (42.3)

 ≥6

42 (49.4)

Chemotherapy regimen

 PF

42 (53.8)

 TPF

21 (26.9)

 TP

15 (19.2)

Local therapy of metastatic lesions

 Yes

18 (21.1)

 RFA

13

 Embolization

4

 Radiotherapy

1

 No

67 (78.9)

Response to chemotherapy

Yes

52 (70.3)

 No

22 (29.7)

 No data

11

  1. PF: Cisplatin + 5-Fu; TPF: Cisplatin + 5-Fu + Paclitaxel; TP: Cisplatin + Paclitaxe;RFA: Radiofrequency ablation.